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Abstract – Objective: To determine the influence of oral fluid sampling methods on drug concentrations.
Methods: Oral fluid was obtained from 249 subjects by Varian OraLab and Statsure Saliva•Sampler. The OraLab
consists of foam-tipped oral fluid collector. The sponge contains a salt that stimulates salivation. The Saliva•Sampler
consists of a collector with a blue indication when 1 mL of oral fluid is collected. After sampling, the collector is
transferred to a tube that contains 1 mL of buﬀer. Oral fluid was analysed for seven drugs with UPLC-MSMS. Results:
For all the tested drugs, the concentrations in the oral fluid collected with OraLab were 37–76% compared to Statsure.
Possible explanations are: a buﬀer and surfactants could explain a better extraction recovery with Statsure (particularly
for THC) and the stimulation of salivation by a salt could explain lower concentrations in OraLab. A comparison of the
concentrations in both samples showed a wide scatter with relatively low correlation coeﬃcients (0.56–0.90). Conclu-
sions: For all tested drugs, the concentrations measured in the oral fluid collected by OraLab are lower. This could have
consequences for the determination of legal cut-oﬀs.
Key words: Saliva, point-of-collection testing, street drugs/analysis
Résumé – Objectif : Déterminer l’influence de la méthode d’échantillonnage dans la salive sur les concentrations des
drogues. Méthodes : La salive a été obtenue chez de 249 sujets par Varian OraLab et Statsure Saliva•Sampler. L’OraLab
se compose d’une tige avec une éponge qui absorbe la salive. L’éponge contient un produit salé qui stimule la salivation.
Le Saliva•Sampler se compose d’un collecteur avec une indication bleue quand 1 mL de salive a été collecté. Après le
prélèvement, le collecteur est transféré dans un tube qui contient 1 mL de tampon. Sept drogues ont été analysées dans
la salive par UPLC-MSMS. Résultats : Pour toutes les drogues testées, les concentrations dans la salive recueillie avec
OraLab étaient de 37–76 % par rapport à Statsure. Les explications possibles de ces diﬀérences sont la présence d’un
tampon et de surfactants qui pourrait expliquer une meilleure extraction avec le Statsure (en particulier pour le THC)
et la stimulation de la salivation par un sel dans l’OraLab pourrait également expliquer les plus faibles concentrations.
La comparaison des concentrations dans les deux échantillons montre une grande dispersion avec des coeﬃcients de
corrélation relativement faibles (0,56-0,90). Conclusions : Pour toutes les drogues, les concentrations mesurées dans
la salive collectées par OraLab sont plus basses. Cela pourrait avoir des conséquences pour la détermination des seuils
médico-légaux.
Mots clés : Salive, tests rapides, analyse de drogues
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Table I. Cut-oﬀs (in µg/L) of the diﬀerent drugs in the diﬀerent legislations on driving under the influence of drugs.
Analyte Belgium Belgium France Victoria
(screening) (confirmation) (screening) (confirmation)
Amphetamine 50 25 50 5*
MDMA 50 25 50 5
THC 25 10 15 2
Cocaine 20 10 10
Benzoylecgonine 20 10 10
6-acetylmorphine 10 5 10
Morphine 10 5 10
* Methamphetamine
1 Introduction
Several countries (e.g. Australia, Belgium, France and
Spain) use oral fluid for drug screening at the roadside in order
to detect drivers under the influence of drugs. The screening
and confirmation cut-oﬀs for the diﬀerent drugs are often men-
tioned in the law. The cut-oﬀs used in the diﬀerent countries
are given in Table I.
The literature has shown that drug concentrations in oral
fluid are aﬀected by many variables. First, oral contamination
can occur after the drug was taken orally or intranasally. It
usually takes about one to two hours for the oral contamination
to disappear [1]. When the oral fluid flow is stimulated, the pH
increases and the drug concentrations decrease [2].
Many basic drugs are present in oral fluid in much higher
concentrations than in blood [3]. This is explained by the phe-
nomenon of ion trapping. When a basic drug reaches the oral
fluid where the pH is a little bit lower, it becomes ionised and
gets a positive charge [2]. Thus, it will not diﬀuse back into the
blood.
O’Neal [4] et al. have shown that concentrations in oral
fluid vary according to the sampling method. The highest con-
centrations were observed in oral fluid that was collected by
spitting. These concentrations averaged 3.6 times higher than
concentrations in specimens collected by acidic stimulation
and 1.3 to 2.0 higher than concentrations in specimens col-
lected by nonacidic stimulation or collection using either the
Salivette or the Finger Collector devices.
The collection device has an influence on the drug con-
centration that is found in the oral fluid [2]. There is variation
in collection volume, volume recovered from the device and
drug recovery from the device [2]. In one study of 5 devices,
between 18% and 83% of the collected oral fluid volume was
recovered [2]. Two important phenomena are adsorption of the
drug on diﬀerent parts of the collection device, and the vari-
able recovery of the drugs from the device. For instance, THC
binds to the Salivette and very little is found in the supernatant
after centrifugation of the Salivette. Extraction of the Salivette
with an organic solvent however releases the THC [5]. Langel
et al. [6] have compared ten sampling devices and found large
diﬀerences in recovery among them. Another issue is the sta-
bility of the drugs once they have been collected by the device.
It is well-known that cocaine is not stable and is hydrolysed to
benzoylecgonine. In some devices, stabilizers and buﬀers have
been added in order to preserve the molecules.
The objective of this study was to determine if various oral
fluid sampling methods yield diﬀerent concentrations for the
main recreational drugs. This study was part of the evaluation
of the sensitivity and specificity of the OraLab [7].
2 Material and methods
Oral fluid was obtained from 249 subjects (who had
given informed consent) by Varian OraLab and Statsure
Saliva•Sampler. Fifty subjects were selected during roadside
surveys and 199 samples were obtained in a rehabilitation
centre for drug addicts. Two oral fluid samples were col-
lected, one with the Varian Oralab 6 (Agilent Technologies,
Santa Clara, CA, USA), and the other with the StatSureTM
Saliva•SamplerTM (Saliva Diagnostic Systems, Framingham,
MA, USA), an oral fluid collector. The latter was chosen be-
cause of the high recovery for all drugs [6].
The Oralab 6 test consists of 3 elements: an oral fluid
collector, a test tube and a test card, as shown in Figure 1A.
The oral fluid collector is a swab with salty taste (to increase
oral fluid production), the test tube contains the oral fluid when
it is squeezed out of the swab and it is shaped to hold the test
card. The test card is the lateral-flow immunoassay to detect
drugs in the oral fluid.
The oral fluid for the sample with the Oralab 6 was col-
lected by keeping the swab under the tongue for about three
minutes, which normally is suﬃcient to collect a minimum of
1mL oral fluid. After collection of the oral fluid with the swab,
the latter was squeezed out in the test tube. The test card was
inserted in the tube to perform the test and removed within
15 min to read the results. The test tube with the remaining
oral fluid was stored at −20 ◦C for later analysis.
A second oral fluid sample was collected with the
StatSureTM Saliva•SamplerTM (Figure 1B). The StatSureTM
oral fluid collector is a cellulose swab that has to be kept under
the tongue to absorb oral fluid. An indicator in the plastic han-
dle turns blue when 1 mL oral fluid is collected. The transport
tube contains 1 mL of buﬀer that dilutes the oral fluid sample.
The concentrations of drugs found in this second sample after
analysis with LC-MS/MS were adjusted for volume, based on
the weight of the StatSureTM device after collection.
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(A)
(B)
Fig. 1. A: Varian OraLab: stem with a sponge that absorbs oral
fluid. The sponge contains an acid product that stimulates salivation.
B: Statsure: collector with a blue indication when 1 mL of oral fluid
is collected. After sampling, the collector is transferred to a tube that
contains 1 mL of buﬀer.
Oral fluid was analysed with UPLC-MSMS on a Quat-
tro PremierTM XE (Waters, Zellik, Belgium), with an Elec-
trospray Ionisation-source in positive mode after liquid-liquid
extraction with heptane/ethyl acetate (1:4). The oral fluid col-
lected with the OraLab was diluted 1:1 with Statsure buﬀer
prior to extraction. The UPLC method has been described else-
where [7].
Passing-Bablok regression was used for calculation of the
slope and intercept (Medcalc, Mariakerke, Belgium). Samples
were included in the calculation if both concentrations were
above the lower limit of quantitation.
3 Results
The median concentrations with both sampling methods,
the Passing-Bablok slope and intercept, and the correlation
coeﬃcient for the diﬀerent drugs are given in Table II. With
the exception of amphetamine (confidence interval 0.5–17),
the intercept was not significantly diﬀerent from zero. For all
the drugs, the concentrations in the oral fluid collected with
OraLab were 37–76% (based on the slope) of those in the sam-
ples obtained with Statsure. The lowest recovery with OraLab
(in comparison to Statsure) was observed for cocaine (37%),
the highest was observed for morphine (76%).
The correlation coeﬃcients varied between 0.56 (cocaine)
and 0.90 (THC). Figures 2–4 show the scatter diagrams and
regression lines for 6-acetylmorphine, codeine and THC.
Table III shows the number of samples that would have
been positive in comparison to the confirmation cut-oﬀs for
the individual drugs in the Belgian legislation. If oral fluid
is sampled with Statsure, there would be 25% more positives
(10–54% depending on the drug).
4 Discussion
Our study showed that the concentrations in oral fluid sam-
pled with OraLab were lower than with Statsure. Possible ex-
planations for the lower recovery with OraLab are: adsorp-
tion of the drugs to the device with OraLab and the presence
of a buﬀer that could explain the better extraction recovery
with Statsure, particularly for THC, while the absence of a
stabilising buﬀer in the OraLab could explain the lower co-
caine concentrations. The stimulation of salivation by a salt
in the OraLab could also explain the lower concentrations ob-
served for all drugs. The diﬀerences however were of the same
magnitude as the diﬀerences that O’Neal et al. [4] observed
for codeine: with spitting the codeine concentrations were
3.6 times higher than with acidic stimulation, 2 times than with
nonacidic stimulation, and 1.3 times than with Salivette or Fin-
ger collector. As in our study the oral fluid was first sampled
with OraLab, and a few minutes later with Statsure, one would
have expected that most concentrations would have been lower
with the latter.
The correlation coeﬃcients in the OraLab-Statsure com-
parison were relatively low (0.56–0.90) and the scatter plots
(Figs. 2–4) show a wide scatter. This also confirms previous
findings that the drug concentrations in oral fluid are not as
constant as in urine or blood, where the sampling method does
not influence the concentration. These large diﬀerences could
again be explained by decreasing concentrations when the oral
fluid production is stimulated, or, in the case of THC, vari-
ations in the adsorption of the THC that is deposited on the
mucosa.
Recently, Gjerde et al. [8] compared zopiclone concentra-
tions in oral fluid sampled with Intercept and Statsure in a
clinical study where 5 and 10 mg of zopiclone were admin-
istered. The concentrations of zopiclone were approximately
2 times higher with the Intercept than with Statsure (no slope
was reported in their paper). They also found that the correla-
tion between the concentrations with the two devices was poor
(r2 = 0.35).
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Table II. Median concentrations, regression line and correlation coeﬃcient of drug concentration measured in oral fluid collected with Statsure
and OraLab.
Drug COC BE THC AMP 6-AM MOR COD
n 39 37 97 32 88 121 111
Median concentration Statsure (ng/mL) 104 191 40 241 128 98 37
Median concentration OraLab (ng/mL) 50 57 17 282 48 52 21
Regression:
Slope 0.37 0.52 0.65 0.69 0.47 0.76 0.75
Intercept 8 5 –2 6 4 0 0
r 0.56 0.83 0.90 0.83 0.75 0.83 0.69
COC: cocaine, BE: benzoylecgonine, THC: tetrahydrocannabinol, AMP: amphetamine, 6-AM: 6-acetylmorphine, MOR: morphine,
COD: codeine.
Fig. 2. Scatter-plot and regression line for the concentrations of 6-acetylmorphine in oral fluid collected with OraLab (Y-axis) and Statsure
(X-axis). Y = 0.47X − 4, r = 0.75.
Very few studies have measured the reproducibility of sam-
pling oral fluid. The only study we are aware of is that of
Niedbala [9], who sampled with the Intercept to the left and
right of the mouth. We calculated the correlation base on the
data in the publications, and found a slope of 0.97 and a r2 of
0.85 (n = 172).
These diﬀerences could have consequences for the deter-
mination of legal cut-oﬀs, as was shown in Table III. With
a sampling method that has a greater recovery, more people
will test positive for drugs. More studies are needed on intra-
individual variability of drug concentrations in oral fluid. In
the USA, when the draft SAMHSA guidelines for workplace
drug testing were written, this was a concern and in the 2004
draft [10], it was recommended to collect oral fluid by spitting,
despite the fact that this collection method is not very practical
nor hygienic.
5 Conclusion
We have shown diﬀerences in drug concentrations when
oral fluid was sampled with two diﬀerent techniques. With the
OraLab, the concentrations were 37–76% compared to Stat-
sure. These diﬀerences were of the same order of magnitude
as in another study. The variation in concentration ratio of the
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Fig. 3. Scatter-plot and regression line for the concentrations of THC in oral fluid collected with OraLab (Y-axis) and Statsure (X-axis).
Y = 0.65X − 2, r = 0.90.
Fig. 4. Scatter-plot and regression line for the concentrations of codeine in oral fluid collected with OraLab (Y-axis) and Statsure (X-axis).
Y = 0.75X, r = 0.69.
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Table III. Number of subjects (n = 249) that would have been posi-
tive above the Belgian confirmation cut-oﬀs in oral fluid, when sam-
pled with the respective devices.
Substance OraLab Statsure Diﬀerence in positive cases
Amphetamine 25 32 +28%
Cannabis (THC) 66 88 +33%
Cocaine 35 54 +54%
Benzoylecgonine 34 48 +41%
6-acetylmorphine 90 108 +20%
Morphine 104 114 +10%
two sampling techniques was also large. If oral fluid is sampled
with the Statsure device approximately 25% more people will
be positive for driving under the influence of drugs under the
Belgian legislation. Only few studies have been performed on
the reproducibility of oral fluid sampling, and more are needed
in order to gain a better understanding of all the variables in-
volved in sampling oral fluid.
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